Ads
related to: BIOTECHNOLOGY VALUE FUND INC- Strategies and Solutions
Mutual Funds. ETFs.
Model Portfolios & more.
- Products
Mutual funds, Model portfolios
Exchange-traded funds
- Global Insights
Latest Insights.
Market Outlook.
- About Us
Meet our leadership team.
Learn about our approach.
- Register Online
Resources
for financial professionals
- Insights
Latest insights
Market outlook
- Strategies and Solutions
Search results
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Stake Decreased by Federated Hermes Inc.
ETF DAILY NEWS· 8 hours agoFederated Hermes Inc. lessened its holdings in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Free Report) by...according to the company in its most recent Form 13F ...
J.W. Cole Advisors Inc. Makes New $283,000 Investment in Avidity Biosciences, Inc. (NASDAQ:RNA)
ETF DAILY NEWS· 8 hours agoThe institutional investor bought 31,292 shares of the biotechnology company’s stock, valued at approximately $283,000. Alps Advisors Inc. lifted its holdings ...
Lindbrook Capital LLC Purchases 52 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)
ETF DAILY NEWS· 6 hours agoLindbrook Capital LLC raised its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free...
Xponance Inc. Sells 203 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
ETF DAILY NEWS· 8 hours agoThe fund owned 8,966 shares of the biotechnology company’s stock after selling 203 shares during the quarter. Xponance Inc.’s holdings ...
RWA Wealth Partners LLC Takes $513,000 Position in United Therapeutics Co. (NASDAQ:UTHR)
ETF DAILY NEWS· 6 hours ago(NASDAQ:UTHR – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 2,332 shares of the biotechnology ...
Equities Analysts Set Expectations for Sarepta Therapeutics, Inc.’s FY2026 Earnings (NASDAQ:SRPT)
ETF DAILY NEWS· 11 hours agoSarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) – Equities research analysts at Zacks Research cut their FY2026...in a report released on Tuesday, April 23rd. Zacks ...
Brokerages Set Biogen Inc. (NASDAQ:BIIB) Price Target at $295.58
ETF DAILY NEWS· 12 hours agoShares of Biogen Inc. (NASDAQ:BIIB – Get Free Report) have earned a consensus rating of “Moderate Buy” from the twenty-seven research firms that are covering the company, ...
Heron Therapeutics, Inc. to Post Q1 2024 Earnings of ($0.09) Per Share, Capital One Financial...
ETF DAILY NEWS· 13 hours agoHeron Therapeutics, Inc. (NASDAQ:HRTX – Free Report) – Equities research analysts at Capital One Financial issued their Q1...Therapeutics in a report released on Tuesday, ...
Aptevo Therapeutics Inc. (NASDAQ:APVO) Short Interest Update
ETF DAILY NEWS· 7 hours agoAptevo Therapeutics Inc. (NASDAQ:APVO – Get Free Report) saw a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling ...
International Assets Investment Management LLC Buys Shares of 18,108 Vir Biotechnology, Inc....
ETF DAILY NEWS· 5 days ago(NASDAQ:VIR – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 18,108 shares ...
Ads
related to: BIOTECHNOLOGY VALUE FUND INC